Changing testing in gastric cancer: a practical review

Dra. Mar Iglesias​Hospital del Mar​Barcelona, Spain​

Biography:
Dra. Mar Iglesias Coma is Head of the Pathology Department at Hospital del Mar (Barcelona), with a specialization in gastrointestinal pathology. Her academic achievements include a doctorate in Medicine and Surgery from the Autonomous University of Medicine. Since 2019, she has been imparting her knowledge as an Associate Professor of Pathology. Additionally, she contributes to the Spanish Society of Anatomical Pathology as an evaluator in Quality Control Program. Her innovative contributions to the Hospital del Mar are noteworthy, particularly in the areas of digital pathology, multidisciplinary tumor committees, biomarkers, and laboratory applications. 

Dr. Manuel Rodriguez-Justo ​
Consultant pathologist at UCL Hospitals ​London, UK​ 

Biography:
Prof Rodriguez-Justo is a consultant in Gastrointestinal Pathology and Hematopathology at UCLH and Professor of Pathology at UCL-Cancer Institute. Manuel has implemented molecular pathways in Gastrointestinal cancers, particularly in colorectal cancer and he was the Clinical Lead at UCLH for the 100K Genomes Project (NHS). His research focuses in tumour heterogeneity studies on known and discovered biomarker signatures, evaluation of lead candidate antibody and small molecule-based therapeutics, genomic and proteomic target quantification using digital image analysis. Manuel has published more than 180 peer-reviewed papers, several reviews and book chapters and has been involved in designing and developing multiple trials. He is also associated editor of Disease of Colon & Rectum and Scientific Reports.

Dr. Matteo Fassan ​Department of Medicine, University of Padua & Department of Pathology​ Marca Trevigiana, Italy

Biography:
Matteo Fassan is Professor of Pathology at Padua University (Padua, Italy) and Director of the Pathology Unit at the Ca' Foncello Hospital, ULSS2 Marca Trevigiana (Treviso, Italy). He is the coordinator of the Italian Group of the Pathologists of the Gastrointestinal Tract of the SIAPeC-IAP (GIPAD). His research is mainly focused on the histological and molecular characterization of pre-neoplastic and neoplastic gastrointestinal pathology, with a peculiar effort on biomarker testing. On these topics he is actively involved in clinical and translational research projects and has authored and co-authored more than 600 peer-reviewed publications.